At ACME medical system, we strive to provide medical devices that are innovative and cutting edge, while still being safe and reliable. Our solution allows for the detection of myocardial ischemia through a patented technology. Currently, we are developing our products even more through third phase of multi-center clinical trials led by University of California, San Francisco. After further trials and research, our products soon will be ready to enter the market. AQED 2000 is a cost-effective, noninvasive, and accurate product that will greatly improve preventive screening procedures. ACME medical system is committed to developing revolutionary products that will advance the medical market.
